Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Critical Care Guidelines
    • Status Epilepticus -...

    Status Epilepticus - Standard Treatment Guidelines

    Written by supriya kashyap kashyap Published On 2016-12-10T09:13:41+05:30  |  Updated On 10 Dec 2016 9:13 AM IST
    Status Epilepticus - Standard Treatment Guidelines

    Status epilepticus (SE) is a state of continuous seizure without return of consciousness. Any seizure type can progress to status epilepticus. Status epilepticus is a serious medical and neurological emergency which requires efficient management as delay is associated with worse outcome. The prognosis depends predominantly on the cause and duration of the SE and is good in rapidly reversible causes. Overall mortality is 15.8 %. Additional 10 to 23% of patients who survived from status epilepticus are left with disability.


    Ministry of Health and Family Welfare has come out with the Standard Treatment Guidelines for Status Epilepticus. Following are its major recommendations.



    Case definition:


    For both situations of care (mentioned below*)


    Clinically definition of SE is based on manifestations of continuous seizure activity and incomplete recovery of consciousness between seizures for a ‘particular duration’. The criterion for duration is still ambiguous and evolving issue. For all practical purposes, a patient should be considered in status epilepticus if seizure activity lasting more than 5 minutes as very few single seizures will last this long.


    Refractory Status Epilepticus (RSE): Appropriate definition is still not available. RSE is commonly defined as seizure activity that continues after failure of first and second line antiepileptic drug therapy (AED) therapy.



    Incidence of The Condition In Our Country


    Chin et al in a recent systemic review reported incidence rates of SE between 3.86 to 38 per 100,000 per year in children and 6 to 27 per 100000 per year in adults in Europe. Incidence has bimodal distribution with peaks in children less than a year (135 to 156 per 100000 per year) and elderly (14.6 to 86 per 100000 per year).The annual incidence of Non convulsive status epilepticus (NCSE) is 2.6 and 7.8 per 100000. NCSE was documented in 8 % of all comatose patients without signs of seizure activity. Frequency of refractory status epilepticus in patients with SE ranged from 31 to 44 %.


    There is hardly any incidence data available in India. In a recent study NCSE was documented as a cause of altered mental status in 10.5% of comatose patients without signs of seizure activity. The incidence of RSE in SE patients in Indian series ranges between 12 and 19 %.



    Differential Diagnosis


    Disorders that may mimic seizures are benign conditions like myoclonus, fasciculations, tremors, tics, panic attack, psychogenic seizures and potentially dangerous conditions like basilar artery transient ischemic attack, metabolic encephalopathy and syncope. When doubt regarding diagnosis is present one should always request neurological consultation and electroencephalogram (EEG). Video- EEG monitoring may be useful for detection of ongoing subclinical seizures and should be considered in critically ill patient with unexplained altered mental status.



    Optimal Diagnostic Criteria, Investigations, Treatment & Referral Criteria


    *Situation 1: At Secondary Hospital/ Non-Metro situation: Optimal Standards of Treatment in Situations where technology and resources are limited



    a) Clinical Diagnosis:


    SE is best divided into three categories:


    Convulsive status epilepticus (CSE)


    Non convulsive status epilepticus (NCSE)


    Partial status epilepticus (PSE)


    CSE is the most common form of SE characterized by rhythmic jerking of the body, limbs, tongue biting and loss of consciousness. With increasing seizure duration the movements may become reduced although generalized electrical activity continues in the brain.


    NCSE may be difficult to diagnose and may be more common in the elderly population. Although there is no accepted classification of NCSE, two major types are partial complex –which is subdivided on the basis that whether the patient has underlying epilepsy or is in coma and petit mal.


    In partial complex SE stereotypical movements such as lip smacking, chewing or picking at ones’ clothes may occur and alteration of consciousness lasts more than 30 minutes as result of abnormal cortical electrical activity.


    Physical examination should look for signs of occult head trauma, substance abuse, fever, meningismus and diabetes. Always check for Medical Alert bracelets or wallet information and try to contact relatives to determine prior medical and seizure history.



    b) Basic Investigations


    Complete blood count , electrolytes ,Blood urea nitrogen(BUN),serum creatinine,glucose,liver function test



    c) Treatment


    Initial general management:




    • Assess basic life support

    • Start supplemental oxygen, monitor oxygen saturation

    • Initiate seizure precautions (e.g., padding bed rails)

    • Monitor vital signs and ECG

    • Adequate venous access and liberal hydration should be started with normal saline to prevent dehydration and rhabdomyolysis.

    • Blood pressure should be monitored closely, especially if seizures persist for more than 30 minute

    • Consider thiamine 100 mg IV and dextrose 25-50 g IV if blood glucose is less than 60 mg/dl



    • Treat fever with acetaminophen and icepacks


    Initial Antiepileptic drug treatment




    • In the setting of acute brain injury, treatment usually should be initiated after a single self limited seizure. Initial AEDs (viz. Lorazepam and phenytoin) should be given as soon as possible.

    • Management of SE should begin within 5 minutes of seizure activity or after two seizures without full recovery in between.

    • Give IV Lorazepam 0.1 mg/kg IV at 2mg/minIf Lorazepam is not immediately available, diazepam 10-20 mg or midazolam 2-5 mg can be substituted

    • Midazolam given intramuscularly is the promising treatment in prehospital settings

    • Start phenytoin 20 mg/kg IV load at <= 50 mg/min


    Referral criteria:


    Patients of SE can be considered for transfer to superspeciality center if seizures are not controlled with benzodiazepine and first line antiepileptic drugs or patient has recurrent seizures after initial stabilization.


    *Situation 2: At Super Specialty Facility in Metro location where higher-end technology is available



    a) Clinical diagnosis


    SE is best divided into three categories:


    Convulsive status epilepticus (CSE)


    Non convulsive status epilepticus (NCSE)


    Partial status epilepticus (PSE)


    CSE is the most common form of SE characterized by rhythmic jerking of the body, limbs, tongue biting and loss of consciousness. With increasing seizure duration the movements may become reduced although generalized electrical activity continues in the brain.


    NCSE may be difficult to diagnose and may be more common in the elderly population. Although there is no accepted classification of NCSE, two major types are partial complex –which is subdivided on the basis that whether the patient has underlying epilepsy or is in coma and petit mal.


    In partial complex SE stereotypical movements such as lip smacking, chewing or picking at ones’ clothes may occur and alteration of consciousness lasts more than 30 minutes as result of abnormal cortical electrical activity.


    Physical examination should look for signs of occult head trauma, substance abuse, fever, meningismus and diabetes. Always check for Medical Alert bracelets or wallet information and try to contact relatives to determine prior medical and seizure history.



    b) Investigation



    • Blood and urine toxicology screen and when indicated pregnancy test and arterial blood gases, serum ammonia level

    • Anticonvulsant medication levels

    • CT or MRI scan and lumbar puncture may be necessary to establish underlying diagnosis once seizures are controlled.

    • NCSE can only be diagnosed by EEG.

    • Investigate to find the underlying cause of seizure









    Common Aetiologies of seizures in critical care unit:


    Neurological :

    Cerebrovascular disease: infarct, haemorrhage, vascular malformation

    Vasculitis

    Infection: meningitis, encephalitis, brain abscess

    Head trauma

    Anoxia

    Brain tumours

    Neurosurgical procedure

    Hypertensive encephalopathy/eclampsia/posterior reversible encephalopathy syndrome

    Complication of Critical illness:

    Acute systemic insult, sepsis, hypotension

    Electrolytes imbalances: hyponatremia, hypocalcaemia, hypomagnesaemia, hypophosphatemia (especially in alcoholics), hypoglycaemia

    Toxins

    Illicit drug use, especially cocaine

    Organ failure: renal, hepatic

    Medications /substance withdrawal: Benzodiazepine, barbiturates, alcohol

    If none of the above causes are identified consider following less common aetiologies:Anti NMDA receptor limbic encephalitis(LE),Anti glutamate receptor LE,Paraneoplastic LE,Hashimotos' encephalopathy.(5)

    c) Treatment


    Additional general management




    • Consider intubation to maintain airway patency

    • Monitor for arrhythmias, hypotension and respiratory failure


    Antepileptic drug treatment




    • Start phenytoin 20 mg/kg IV load at <= 50 mg/min or Fosphenytoin at 20 mg phenytoin equivalents (PE)/kg at =< 150 mg PE/min

    • Seizure activity not resolving with two anticonvulsants:

    • Give Phenobarbital 10-20 mg/kg IV at <70 mg/min.

    • Call for continuous EEG monitoring

    • Consider neurological consultation

    • Consider administration of following alternative agents:

    • Midazolam drip: 0.2 mg/kg slow IV push, followed by 0.1-2 mg/kg/hr to stop electrographic and clinical seizures or

    • Propofol: 2 mg/kg load and 2-10 mg/kg/hr to stop clinical and electrographic seizures or maintain burst suppression on EEG

    • Valproate 15 mg/kg IV load may be useful as an adjunctive agent.

    • Pentobarbital 3-5 mg/kg IV to induce burst suppression; in most adults pentobarbital bolus 400 mg over 15 min. every 15-30 min. until burst suppression appears is well tolerated, followed by infusion at 0.3-9.0 mg/kg/hr to maintain burst suppression.(7),(8)

    • For all infusions, decrease infusion rate periodically to check EEG burst suppression pattern; if electro cerebral silence occurs, decrease the dose till bursts are seen again.(4)


    Guidelines by The Ministry of Health and Family Welfare :


    FN Kapadia, Consultant Physician & Intensivist, PD Hinduja National Hospital, Mumbai


    Prashant Walse, Associate Intensive Care Unit Consultant, PD Hinduja National Hospital, Mumbai

    guideline on Status EpilepticusMinistry of Health and Family WelfareNCSENon convulsive status epilepticusStandard Treatment GuidelinesStatus Epilepticus

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok